VAERS Explorer
Back to explore

Report #2889051

Received Mar 16, 2026

ER / ED visit
A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
NC
Recovered
Not recovered
Vaccinated
Mar 2, 2026
Onset
Mar 5, 2026
Days to onset
3
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
MNQMENINGOCOCCAL CONJUGATE (MENVEO)NOVARTIS VACCINES AND DIAGNOSTICSUNK7742a—

Symptoms (1)

Rash

Symptom narrative

Full body rash; This non-serious case was reported by a other health professional and described the occurrence of generalized rash in a 11-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number 7742a, expiry date 31-JAN-2027) for prophylaxis. On 02-MAR-2026, the patient received Menveo .5 ml. On 05-MAR-2026, 3 days after receiving Menveo, the patient experienced generalized rash (Verbatim: Full body rash). The outcome of the generalized rash was not resolved. It was unknown if the reporter considered the generalized rash to be related to Menveo. It was unknown if the company considered the generalized rash to be related to Menveo. Additional Information: GSK Receipt Date: 06-MAR-2026 A patient received Menveo vaccine on 02-MAR-2026.; Sender's Comments: US-GSK-US2026031119:SAME REPORTER